Skip to main content

Leukemia

CLL1-CD33 Compound CAR (cCAR) T-Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia

Monitoring Methotrexate Levels in a Patient After Glucarpidase Administration: A Case Report

Savannah L. Gulley, PharmD; Kyle A. Franco, PharmD, BCPPS; Joshua J. Elder, PharmD, BCPS, BCOP

Meeting Highlights

Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL

Meeting Highlights

First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL

Meeting Highlights

Investigational Oral Form of Azacitidine Improves Survival Maintenance Therapy in Patients with Acute Myeloid Leukemia

Meeting Highlights

All-Oral Time-Limited Combination Treatment for CLL or SLL Shows Early Impressive Efficacy

What Is the Role of Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukemia?

Meg Barbor, MPH

November 25, 2019 – Oncology News & Updates

November 4, 2019 — Oncology News & Updates

Daurismo (Glasdegib) Approved, in Combination with Low-Dose Cytarabine, for Newly Diagnosed Acute Myeloid Leukemia in Older Adults or Those Unfit for Intensive Chemotherapy

4
5
6
7
8

Page 7 of 8
Results 61 - 70 of 78